Absence of Reelin results in altered nociception and aberrant neuronal positioning in the dorsal spinal cord.
Mutations in reeler, the gene coding for the Reelin protein, result in pronounced motor deficits associated with positioning errors (i.e. ectopic locations) in the cerebral and cerebellar cortices. In this study we provide the first evidence that the reeler mutant also has profound sensory defects. We focused on the dorsal horn of the spinal cord, which receives inputs from small diameter primary afferents and processes information about noxious, painful stimulation. We used immunocytochemistry to map the distribution of Reelin and Disabled-1 (the protein product of the reeler gene, and the intracellular adaptor protein, Dab1, involved in its signaling pathway) in adjacent regions of the developing dorsal horn, from early to late embryonic development. As high levels of Dab1 accumulate in cells that sustain positioning errors in reeler mutants, our findings of increased Dab1 immunoreactivity in reeler laminae I-III, lamina V and the lateral spinal nucleus suggest that there are incorrectly located neurons in the reeler dorsal horn. Subsequently, we identified an aberrant neuronal compaction in reeler lamina I and a reduction of neurons in the lateral spinal nucleus throughout the spinal cord. Additionally, we detected neurokinin-1 receptors expressed by Dab1-labeled neurons in reeler laminae I-III and the lateral spinal nucleus. Consistent with these anatomical abnormalities having functional consequences, we found a significant reduction in mechanical sensitivity and a pronounced thermal hyperalgesia (increased pain sensitivity) in reeler compared with control mice. As the nociceptors in control and reeler dorsal root ganglia are similar, our results indicate that Reelin signaling is an essential contributor to the normal development of central circuits that underlie nociceptive processing and pain.
Villeda
S A
SA
Department of Physiological Science, UCLA, Los Angeles, CA 90095-1606, USA.
Akopians
A L
AL
Babayan
A H
AH
Basbaum
A I
AI
Phelps
P E
PE
D048868:Adaptor Proteins, Signal Transducing / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D001522:Behavior, Animal; D015816:Cell Adhesion Molecules, Neuronal / Q000172:deficiency*; D002452:Cell Count / Q000379:methods; D004622:Embryo, Mammalian; D016326:Extracellular Matrix Proteins / Q000172:deficiency*; D018507:Gene Expression Regulation, Developmental / Q000502:physiology*; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D008297:Male; D051379:Mice; D008818:Mice, Neurologic Mutants; D009419:Nerve Tissue Proteins / Q000172:deficiency* / Q000378:metabolism; D010147:Pain Measurement / Q000379:methods; D020671:Posterior Horn Cells / Q000502:physiology*; D018040:Receptors, Neurokinin-1 / Q000378:metabolism; D011957:Receptors, Opioid / Q000502:physiology*; D000091042:Reelin Protein; D012697:Serine Endopeptidases / Q000172:deficiency*; D012737:Sex Factors; D013116:Spinal Cord / Q000166:cytology* / Q000201:enzymology / Q000254:growth & development; D000094942:Nociceptin Receptor
D048868:Adaptor Proteins, Signal Transducing; D015816:Cell Adhesion Molecules, Neuronal; C499786:Dab1 protein, rat; D016326:Extracellular Matrix Proteins; D009419:Nerve Tissue Proteins; D018040:Receptors, Neurokinin-1; D011957:Receptors, Opioid; D000091042:Reelin Protein; C000717129:Reln protein, rat; C000717127:RELN protein, human; C000717128:Reln protein, mouse; D012697:Serine Endopeptidases; D000094942:Nociceptin Receptor